<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: New Insights for Product Development and Bioequivalence Assessments of Generic Orally Inhaled and Nasal Drug Products; Public Workshop; Request for Comments</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: New Insights for Product Development and Bioequivalence Assessments of Generic Orally Inhaled and Nasal Drug Products; Public Workshop; Request for Comments</h1>
    <p class="timestamp">Published: 2017-12-19 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public workshop entitled "New Insights for Product Development and Bioequivalence Assessments of Generic Orally Inhaled and Nasal Drug Products." The purposes of the workshop are to present the outcomes from the research projects conducted under the Generic Drug User Fee Amendments (GDUFA) Regulatory Science Research Program; discuss how regulatory science initiatives have helped address regulatory science know...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2017-27279</p>
    <p><strong>Publication Date:</strong> 2017-12-19</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2017/12/19/2017-27279/new-insights-for-product-development-and-bioequivalence-assessments-of-generic-orally-inhaled-and">https://www.federalregister.gov/documents/2017/12/19/2017-27279/new-insights-for-product-development-and-bioequivalence-assessments-of-generic-orally-inhaled-and</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2017-27279</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
